Abstract
The present invention provides a polypeptide comprising a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3, or a variant thereof at least 90% identical to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3. The invention also provides an antibody that binds to the polypeptide, a nucleic acid molecule encoding the polypeptide, a process for producing the polypeptide, a process for amplifying a nucleic acid, a process for producing closed linear DNA, and a kit comprising the polypeptide.
Full Text
What is claimed is:
The present invention provides a polypeptide comprising a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3, or a variant thereof at least 90% identical to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3. The invention also provides an antibody that binds to the polypeptide, a nucleic acid molecule encoding the polypeptide, a process for producing the polypeptide, a process for amplifying a nucleic acid, a process for producing closed linear DNA, and a kit comprising the polypeptide.
Timeline
Filed
02/27/2026Published
06/25/2026Granted
Not AvailableIPC Codes(4)
C12N 9/12:transferring phosphorus containing groups, e.g. kinases (2.7)
C12P 19/34:Polynucleotides, e.g. nucleic acids, oligoribonucleotides
C12Q 1/6853:using modified primers or templates